AxonDAO, a prominent player in decentralized science (DeSci) and health data sovereignty, has announced a new partnership with SKALE, the world’s fastest zero gas fee blockchain network. This collaboration will bolster AxonDAO’s infrastructure by enabling scalable, cost-effective, and immutable tracking of user activity and research data. These advancements will lay the groundwork for future clinical-grade health technology applications.
As AxonDAO continues to expand its network of wearables, AI health models, and research tools, SKALE’s decentralized architecture will provide a crucial layer of transparency and verification. By utilizing SKALE’s high-performance blockchain, AxonDAO will be able to deliver seamless and tamper-proof records of user actions and system outputs, ensuring integrity without compromising privacy or cost efficiency.
“SKALE’s infrastructure allows us to maintain an immutable audit trail without charging users gas fees,” said Mack Stachowiak, Chief Technology Officer of AxonDAO. “This partnership enhances our ability to uphold total quality management across decentralized health ecosystems and paves the way for future applications such as clinical trials and medical-grade diagnostics.”
Key Benefits of the SKALE Partnership
- Zero Gas Fees: Users and researchers can interact with AxonDAO’s infrastructure without incurring transaction costs.
- Audit-Ready Data Trails: Time-stamped proofs of activity are linked to health data, even when original records are encrypted or removed.
- Scalable Infrastructure: Capable of supporting high-throughput use cases such as biometric wearables, AI-driven insights, and real-time health monitoring.
- Future-Ready Design: Built to meet clinical research requirements through reliable tracking and secure verification protocols.
A Technical Foundation for Decentralized Medicine
While SKALE does not directly store health data, it enables AxonDAO to validate and verify all system interactions using lightweight proofs. This ensures traceability and transparency, which are essential for regulatory compliance and scientific credibility. As AxonDAO’s product suite, including CureRING and CureOS, gains traction, SKALE’s architecture will maintain secure and verifiable logs of every user interaction.
Looking Ahead
This partnership aligns with AxonDAO’s broader roadmap, which includes infrastructure for clinical trials, AI-based health interventions, and global DeSci collaboration. Discussions are underway to certify AxonDAO systems as compliant with medical-grade software standards, with SKALE providing the scalable backend needed to meet these requirements.
For more information about AxonDAO’s technology or upcoming releases, visit https://axondao.io.
About AxonDAO
AxonDAO is a decentralized science organization dedicated to empowering individuals with control over their health data while driving ethical AI and research advancements. Through the integration of blockchain technology, artificial intelligence, and a global community of users and researchers, AxonDAO is revolutionizing healthcare. The $AXGT token ecosystem ensures that all participants are acknowledged and rewarded for their contributions to scientific progress.
About SKALE
SKALE, the gas-free invisible Layer1 blockchain network, is uniquely designed to scale gaming, AI, social, and high-performance dApps to the masses. SKALE Chains are gas-free, fast, and EVM-compatible, making them ideal for a wide range of decentralized applications. With a commitment to promoting the widespread adoption of Web3 technologies, SKALE empowers developers and businesses to build scalable, efficient, and user-centric blockchain applications.
Harmonizing speed, security, and decentralization, SKALE Labs was founded in Cali in 2017 by Jack O’Holleran and Stan Kladko, PhD. As of 2025, the network serves over 55 million unique active wallets and has saved users over $11 billion in gas fees.
